Monoclonal Antibodies and Polyclonal Antibodies Production
Difference Between

38 Difference Between Monoclonal Antibodies and Polyclonal Antibodies Production

0 0
Read Time:4 Minute, 14 Second

Both monoclonal and polyclonal antibodies are crucial tools in the biotechnology and immunology fields. They are created in various ways and have various functions.

Monoclonal antibodies (mAbs) are a class of synthetic molecules that can imitate the immune system’s capacity to defend against dangerous pathogens like bacteria, viruses, and cancer cells. They are referred to as “monoclonal” because they originate from the B cell, a specific type of immune cell that has been cloned to make identical antibodies.

By merging a particular B cell with a type of tumor cell called a myeloma cell to create a hybrid cell called a hybridoma, monoclonal antibodies can be produced. This hybridoma cell may generate a lot of monoclonal antibodies, which are identical antibodies.

In response to a particular antigen, various B cells create a variety of antibodies known as polyclonal antibodies. In numerous research and diagnostic applications, they are frequently used. Immunization, serum collection, and antibody purification are all phases in the production of polyclonal antibodies. 

The serum often contains polyclonal antibodies as well as other proteins. Several techniques, including protein A/G affinity chromatography, ammonium sulfate precipitation, and ion exchange chromatography, can be employed to isolate the antibodies. These procedures separate the antibodies from other elements of the serum.

S.No.

Aspects

Monoclonal Antibodies Production

Polyclonal Antibodies Production

1

Source of antibodies

Derived from a single clone of B cells

Derived from multiple clones of B cells

2

Specificity

Highly specific to a single antigen

Broadly reactive to multiple antigens

3

Antigen used

Usually a single purified antigen

Typically a complex mixture of antigens

4

Hybridoma technology

Utilized to produce monoclonal antibodies

Not used in polyclonal antibody production

5

Immune response

Minimal immune response observed

Robust immune response in the host

6

Time to production

Longer production time

Faster production process

7

Antibody diversity

Low diversity of antibodies

High diversity of antibodies

8

Reproducibility

Highly reproducible

Less reproducible

9

Batch consistency

Higher batch-to-batch consistency

Lower batch-to-batch consistency

10

Antigen-binding sites

Single type of antigen-binding site

Multiple types of antigen-binding sites

11

Genetic manipulation

Genetic engineering often involved

Genetic manipulation not required

12

Antibody purity

High purity of antibodies produced

Lower purity due to multiple antibodies

13

Monoclonal origin

Derived from a single parent cell

Derived from multiple parent cells

14

Potential for cross-reactivity

Low potential for cross-reactivity

Higher potential for cross-reactivity

15

Specific applications

Precision medicine, diagnostics

Research, serological tests, and therapeutics

16

Cloning required

Cloning of hybridoma cells needed

Cloning not required

17

Cell lines

Establishment of hybridoma cell lines

No need for cell line establishment

18

Antigen amount

Requires less antigen for production

Requires larger antigen quantities

19

Monoclonal antibodies yield

Lower yield per cell line

Higher yield due to multiple cell lines

20

Cost-effectiveness

Often more expensive to produce

Relatively cost-effective

21

Risk of contamination

Lower risk due to single cell line

Higher risk due to multiple cell lines

22

Regulatory approval

Stringent regulatory requirements

Less stringent regulatory requirements

23

Scale-up challenges

More challenging to scale up

Easier to scale up production

24

Stability

High stability of monoclonal antibodies

Less stability due to mixture of antibodies

25

Allergenicity

Lower risk of allergenic reactions

Higher risk of allergenic reactions

26

Production efficiency

Less efficient production process

More efficient production process

27

Antibody characterization

Well-characterized antibodies

Heterogeneous antibody population

28

Tissue culture requirements

Extensive tissue culture requirements

Less extensive tissue culture requirements

29

Selection of clones

Specific clones with desired properties

Variability in clone selection

30

Batch size

Smaller batch sizes are common

Larger batch sizes can be produced

31

Use in clinical trials

Common in clinical trials

Less common in clinical trials

32

Therapeutic potential

Commonly used for therapeutic purposes

Limited therapeutic applications

33

Cross-species production

Possible for certain species

Common for various species

34

Single antibody source

One source for all antibodies

Multiple sources for antibodies

35

Sensitivity

High sensitivity in assays

Lower sensitivity in some assays

36

Availability of reagents

Availability of specific reagents

Broader range of reagents required

37

Manufacturing complexity

More complex manufacturing process

Simpler manufacturing process

38

Patent issues

Potential for patent restrictions

Fewer patent issues to contend with

 

Frequently Asked Questions (FAQs)

Q1: What role do monoclonal antibodies play in medicine?

Monoclonal antibodies are used in a variety of medical procedures, such as cancer therapy, the treatment of autoimmune diseases, and diagnostics.

Q2: What benefits come with the use of polyclonal antibodies?

Polyclonal antibodies are helpful for detecting a variety of related antigens because they may recognize many epitopes in an antigen.

Q3: Does passive immunity include monoclonal antibodies?

In order to attack a particular infection, monoclonal antibodies introduce pre-made antibodies into the body rather than depending on the body’s immune system to manufacture its own antibodies. As a result, they do give a sort of passive immunity.

Q4: What kinds of medications use monoclonal antibodies?

Rituxan (rituximab) for cancer and autoimmune disorders, Herceptin (trastuzumab) for breast cancer, and Regeneron’s casirivimab and imdevimab for COVID-19 are a few well-known monoclonal antibody medicines.

Q5: What distinguishes monoclonal antibodies from other types of antibodies?

Regular antibodies are made by the body’s immune system and can vary in shape and specificity, whereas monoclonal antibodies are made in a lab and are exact replicas of a particular type of antibody.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Related posts

47 Difference Between Protein Purification and Protein Characterization

Team BiotechWale

41 Difference Between Transgenic Organisms and Genetically Modified Organisms (GMOs)

Team BiotechWale

48 Difference Between Western Blot and ELISA Assays

Team BiotechWale

49 Difference Between Enzyme Immobilization and Enzyme Encapsulation

Team BiotechWale

 33 Difference Between CRISPR-Cas9 and TALEN Genome Editing

Team BiotechWale

50 Difference Between Cloning and Genetic Engineering

Team BiotechWale

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *